HF
VNRX icon

HRT Financial’s VolitionRx Ltd VNRX Stock Holding History

HRT Financial’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-828
Closed -$11K – 4120
2025
Q3 		$11K Buy
828
+228
+38% +$3.03K ﹤0.01% 2747
2025
Q2 		$9K Buy
+600
New +$6.61K ﹤0.01% 2459
2021
Q4 		– Sell
-3,279
Closed -$203K – 4159
2021
Q3 		$203K Buy
3,279
+150
+5% +$9.5K ﹤0.01% 2681
2021
Q2 		$205K Buy
+3,129
New +$212K ﹤0.01% 2372

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial's VNRX Position: Q4 2025 in Review

HRT Financial sold out of VolitionRx Ltd (VNRX) in Q4 2025, closing a stake of 828 shares — an estimated $11K sold.

HRT Financial first reported a position in VNRX in Q2 2021 and held it in 4 quarters. The position peaked at $205K in Q2 2021. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2025.

  • HRT Financial reported no remaining VolitionRx Ltd position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 828 VolitionRx Ltd shares in Q4 2025, an estimated $11K.
  • HRT Financial first reported a position in VolitionRx Ltd in Q2 2021 and held it in 4 quarters.
  • HRT Financial's VolitionRx Ltd position peaked at $205K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.